
Eyestem
Developer of scalable cell replacement therapies designed to treat incurable diseases. The company's platform aims to replace damaged photoreceptor cells in the eye with healthy, transplantable cells ...
Valuation
$0
Share Price
N/A
Total Raised
$20M
Last Round
N/A